IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 118 filers reported holding IMMUNOVANT INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $47,027,750 | +350.7% | 1,225,000 | +122.7% | 2.74% | +369.7% |
Q2 2023 | $10,433,500 | +146850.7% | 550,000 | +37.5% | 0.58% | +22.9% |
Q4 2022 | $7,100 | -99.9% | 400,000 | +18.7% | 0.48% | +295.8% |
Q1 2021 | $5,406,000 | -92.5% | 337,048 | -78.4% | 0.12% | -93.0% |
Q4 2020 | $72,193,000 | +25.3% | 1,562,952 | -4.6% | 1.72% | -22.5% |
Q3 2020 | $57,639,000 | – | 1,637,951 | – | 2.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Global Management, LLC | 3,007,000 | $25,620,000 | 3.77% |
Deep Track Capital, LP | 4,775,000 | $40,683,000 | 2.87% |
Octagon Capital Advisors LP | 572,862 | $4,881,000 | 0.95% |
Eventide Asset Management | 4,950,000 | $42,174,000 | 0.54% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,197,000 | 0.44% |
FRAZIER MANAGEMENT LLC | 585,759 | $4,991,000 | 0.38% |
MANGROVE PARTNERS IM, LLC | 688,000 | $5,862,000 | 0.35% |
BCK CAPITAL MANAGEMENT LP | 54,293 | $463,000 | 0.31% |
EcoR1 Capital, LLC | 1,140,819 | $9,720,000 | 0.31% |
MANGROVE PARTNERS IM, LLC | 570,400 | $4,860,000 | 0.29% |